Klebsiella pneumoniae is a Gram-negative bacterium responsible for various healthcare-associated infections, including pneumonia, bloodstream infections, and surgical site infections. The emergence of carbapenem-resistant strains, particularly those producing Klebsiella pneumoniae carbapenemase (KPC), poses significant treatment challenges. Accurate detection of these resistant strains is crucial for effective patient management and infection control.
Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!
By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Contact Us” page you agree to the transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be governed by our Privacy Statement.